Brief: Integrum AB Says Granted Premarket Approval By FDA For Opra Implant System
18/12/2020 23:34
Dec 18 (Reuters) - Integrum AB INTEGb.ST :
* INTEGRUM AB GRANTED PMA (PREMARKET APPROVAL) BY THE FDA
FOR THE
OPRA ™ IMPLANT SYSTEM
Source text for Eikon: ID:nWkrbDsnbC
Further company coverage: INTEGb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Integrum AB
See all newsBrief: Integrum Announces Publication Of Study On OPRA Implant System
Brief: Integrum Says Ukraine To Launch State-Funded Osseointegration Pilot Program
Sweden's Integrum Q1 sales rise on higher S1 surgeries
Brief: Integrum Q1 EBIT SEK 1.3 Million
Brief: Integrum Gets Additional Custom Duty Refund Of About SEK 3.3 Mln